Thomas E. Wiese

Thomas E. Wiese is a Professor of Biochemistry at Xavier University of Louisiana's College of Pharmacy, with tenure. He serves as the Xavier Associate Director of the Louisiana Cancer Research Consortium (LCRC), Director of the Investigator Development Core and Cell-Molecular Core in Xavier's NIH-funded Research Center in Minority Institutions (RCMI) program. His roles focus on advancing cancer research, faculty development, and student research involvement.

• Education:
• Ph.D. in Biochemistry, Wayne State University School of Medicine (1995)
• Post-Doctoral Fellowship in Toxicology, University of North Carolina at Chapel Hill (1995–1998)
• B.S. in Biology, University of Michigan-Flint (1984)

Dr. Wiese's research centers on molecular mechanisms of endocrine disruption, particularly how environmental chemicals, pharmaceuticals, and natural products influence hormone-mediated cancer promotion. His lab employs cellular, molecular, and computational methods to study estrogen, androgen, and progestin activity in cancer contexts. He teaches molecular biology, biochemistry, and cancer biology to PharmD students and has a history of collaborative research across Tulane, LSU, and Ochsner institutions.

His administrative roles include directing cores supporting cancer research infrastructure and investigator development at Xavier. While no specific grants or awards are detailed, his leadership in interdisciplinary initiatives underscores his contributions to minority-serving research institutions.

Dr. Wiese's lab actively involves PharmD students in research, fostering hands-on training in endocrine disruption studies. His career transitioned from joint faculty positions at Tulane and Xavier (1998–2003) to full-time focus at Xavier, emphasizing translational cancer research and educational mentorship.